SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea
· Delayed Price · Currency is KRW 1,969.00
0.00 (0.00%)
At close: Aug 13, 2025, 3:30 PM KST
SLS BIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 |
| Net Income | 3.3 | 335.63 | 1,434 | 2,826 | 204.47 | 321.8 |
| Depreciation & Amortization | 1,336 | 1,336 | 1,278 | 1,303 | 616.03 | 660.07 |
| Loss (Gain) From Sale of Assets | -0.14 | 0 | 0.01 | -40.3 | -4 | - |
| Loss (Gain) on Equity Investments | - | - | 39.06 | 236.35 | - | - |
| Stock-Based Compensation | 2.28 | 3.75 | 11.77 | 32.79 | - | - |
| Provision & Write-off of Bad Debts | 78.88 | 77.64 | 133.87 | 34.87 | 21.57 | - |
| Other Operating Activities | 464.71 | 467.69 | -139.84 | -278.15 | 324.4 | 382.99 |
| Change in Accounts Receivable | 368.53 | 118.11 | 1,076 | -202.97 | -564.81 | -604.44 |
| Change in Inventory | 8.64 | 8.64 | 74.96 | -99.5 | - | - |
| Change in Accounts Payable | -338.06 | -472.39 | 339.59 | 82.83 | 14.99 | -34.4 |
| Change in Other Net Operating Assets | -235.49 | -149.13 | -812.36 | 138.74 | 112.13 | 154.94 |
| Operating Cash Flow | 1,689 | 1,726 | 3,436 | 4,034 | 724.79 | 880.96 |
| Operating Cash Flow Growth | -50.38% | -49.76% | -14.83% | 456.58% | -17.73% | - |
| Capital Expenditures | -1,169 | -1,456 | -1,274 | -719.23 | -627.13 | -35.08 |
| Sale of Property, Plant & Equipment | 0.2 | - | - | 203.64 | 4 | - |
| Sale (Purchase) of Intangibles | -41.4 | -43.37 | -134.44 | -15.39 | -348.6 | -488.51 |
| Investment in Securities | 995.32 | 997.32 | -6,509 | -1,012 | -1,499 | - |
| Other Investing Activities | -0 | -0 | -0.78 | -0.52 | -71.52 | 2 |
| Investing Cash Flow | -214.97 | -502.34 | -7,918 | -1,543 | -2,538 | -516.99 |
| Short-Term Debt Issued | - | - | - | - | - | 320 |
| Long-Term Debt Issued | - | - | - | - | 200 | - |
| Total Debt Issued | - | - | - | - | 200 | 320 |
| Short-Term Debt Repaid | - | - | - | -1,770 | -312 | -12 |
| Long-Term Debt Repaid | - | -589.58 | -579.91 | -574.71 | -1,124 | -607.95 |
| Total Debt Repaid | -594.06 | -589.58 | -579.91 | -2,345 | -1,436 | -619.95 |
| Net Debt Issued (Repaid) | -594.06 | -589.58 | -579.91 | -2,345 | -1,236 | -299.95 |
| Issuance of Common Stock | - | - | 5,660 | - | 3,626 | - |
| Repurchase of Common Stock | -899.88 | -899.88 | - | - | - | - |
| Dividends Paid | -383.71 | -383.71 | - | - | - | - |
| Other Financing Activities | -27.8 | -27.8 | -302.2 | - | -187.77 | -26 |
| Financing Cash Flow | -1,905 | -1,901 | 4,777 | -2,345 | 2,203 | -325.95 |
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | -0 | - | - |
| Net Cash Flow | -431.6 | -677.09 | 294.84 | 146.05 | 389.11 | 38.02 |
| Free Cash Flow | 519.72 | 269.92 | 2,162 | 3,315 | 97.66 | 845.88 |
| Free Cash Flow Growth | -74.56% | -87.51% | -34.79% | 3294.14% | -88.45% | - |
| Free Cash Flow Margin | 6.43% | 3.22% | 23.96% | 30.83% | 1.57% | 14.53% |
| Free Cash Flow Per Share | 30.42 | 17.66 | 153.75 | 483.26 | 19.58 | 194.51 |
| Cash Interest Paid | - | - | - | 23.37 | 175.57 | 198.4 |
| Cash Income Tax Paid | 34.29 | 36.53 | 6.47 | 1.09 | 3.06 | -0.02 |
| Levered Free Cash Flow | -20.23 | -3.66 | 1,255 | - | -559.57 | - |
| Unlevered Free Cash Flow | 29.47 | 48.79 | 1,318 | - | -349.34 | - |
| Change in Working Capital | -196.39 | -494.76 | 678.68 | -80.9 | -437.68 | -483.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.